Within hours of each other, two molecular labs focusing on women's health raised collectively $205M.
Counsyl raised $80M (here). Progenity raised $125M (here).
In other news, on November 7, a publicly held company in germline genetics, Invitae, had a stock pop of 13% based on growing revenues (here.) Invitae announced a $73M private placement offering a couple months ago (here). Germline genetics company Ambry recently sold to Konica Minolta in a deal valued up to $1B (here).